Dempski, Robert E.
Rolle, Marsha W.
University of Massachusetts Medical Center
Dr. Gang Han
Upconverting nanoparticles (UCNP) were characterized as siRNA transfection agents, in an approach to target superoxide dismutase 1 (SOD1), a protein implicated in amyotrophic lateral sclerosis. Two UCNP designs were tested: (1) NaYF4:Yb,Er@NaYF4 core/shell nanoparticles with polyethylene imine (PEI) coating and (2) NaYF4:Yb,Er@CaF2 core/shell nanoparticles with a citric acid/PEI coating. The NaYF4-shell particles exhibited a low toxic range, but effective plasmid and siRNA delivery, quantified through green fluorescent protein (GFP) expression and SOD1 knockdown in Western blots. The CaF2–shell particles had a greater working range, but were less effective for payload delivery. Continued research is needed to optimize a UCNP with high cell tolerance and high transfection efficiency.
Worcester Polytechnic Institute
Major Qualifying Project
All authors have granted to WPI a nonexclusive royalty-free license to distribute copies of the work, subject to other agreements. Copyright is held by the author or authors, with all rights reserved, unless otherwise noted.
Chemistry and Biochemistry
Your accessibility may vary due to other restrictions.